{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:05:34Z","timestamp":1787061934099,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00415-017-8583-z","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T01:54:19Z","timestamp":1501638859000},"page":"1945-1955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["MOG antibody-related disorders: common features and uncommon presentations"],"prefix":"10.1007","volume":"264","author":[{"given":"\u00c1lvaro","family":"Cobo-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyacintha","family":"D\u2019Indy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Poulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Durand-Dubief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaran","family":"Deiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Desportes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"8583_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Pr\u00f6bstel","year":"2011","unstructured":"Pr\u00f6bstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580\u2013588","journal-title":"Neurology"},{"key":"8583_CR2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","volume":"69","author":"K Rostasy","year":"2012","unstructured":"Rostasy K, Mader S, Schanda K et al (2012) Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 69:752\u2013756","journal-title":"Arch Neurol"},{"key":"8583_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","volume":"86","author":"M Baumann","year":"2014","unstructured":"Baumann M, Sahin K, Lechner C et al (2014) Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 86:265\u2013272","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8583_CR4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","volume":"22","author":"M Baumann","year":"2016","unstructured":"Baumann M, Hennes E-M, Schanda K et al (2016) Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler 22:1821\u20131829","journal-title":"Mult Scler"},{"key":"8583_CR5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/1352458512466317","volume":"19","author":"P Huppke","year":"2013","unstructured":"Huppke P, Rostasy K, Karenfort M et al (2013) Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 19:941\u2013946","journal-title":"Mult Scler"},{"key":"8583_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474\u2013481","journal-title":"Neurology"},{"key":"8583_CR7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71:276\u2013283","journal-title":"JAMA Neurol"},{"key":"8583_CR8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","volume":"21","author":"R H\u00f6ftberger","year":"2014","unstructured":"H\u00f6ftberger R, Sepulveda M, Armangue T et al (2014) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler. 21:866\u2013874","journal-title":"Mult Scler."},{"key":"8583_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280","journal-title":"J Neuroinflammation"},{"key":"8583_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","volume":"264","author":"J Havla","year":"2016","unstructured":"Havla J, K\u00fcmpfel T, Schinner R et al (2016) Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol 264:139\u2013151","journal-title":"J Neurol"},{"key":"8583_CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458515587751","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas-Lowy D, Musallam A et al (2016) Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 22:174\u2013184","journal-title":"Mult Scler"},{"key":"8583_CR12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","volume":"21","author":"IA Ketelslegers","year":"2015","unstructured":"Ketelslegers IA, Van Pelt DE, Bryde S et al (2015) Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 21:1513\u20131520","journal-title":"Mult Scler"},{"key":"8583_CR13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","volume":"263","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangue T, Martinez-Hernandez E et al (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263:1349\u20131360","journal-title":"J Neurol"},{"key":"8583_CR14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","volume":"23","author":"ED Pelt van","year":"2015","unstructured":"van Pelt ED, Wong YYM, Ketelslegers IA et al (2015) Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol 23:580\u2013587","journal-title":"Eur J Neurol"},{"key":"8583_CR15","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1212\/NXI.0000000000000175","volume":"2","author":"F Pauli Di","year":"2015","unstructured":"Di Pauli F, H\u00f6ftberger R, Reindl M et al (2015) Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflam 2:e175","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"8583_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","volume":"2","author":"M Spadaro","year":"2015","unstructured":"Spadaro M, Gerdes LA, Mayer MC et al (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2:295\u2013301","journal-title":"Ann Clin Transl Neurol"},{"key":"8583_CR17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP et al (2013) International pediatric multiple sclerosis study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261\u20131267","journal-title":"Mult Scler"},{"key":"8583_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"8583_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302","journal-title":"Ann Neurol"},{"key":"8583_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.55.8.671","volume":"55","author":"C Confavreux","year":"1992","unstructured":"Confavreux C, Compston DA, Hommes OR et al (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55:671\u2013676","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8583_CR21","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e318296e917","volume":"80","author":"R Marignier","year":"2013","unstructured":"Marignier R, Bernard-Valnet R, Giraudon P et al (2013) Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 80:2194\u20132200","journal-title":"Neurology"},{"key":"8583_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","volume":"22","author":"\u00c1 Cobo-Calvo","year":"2015","unstructured":"Cobo-Calvo \u00c1, Sep\u00falveda M, Bernard-Valnet R et al (2015) Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications. Mult Scler. 22:312\u2013319","journal-title":"Mult Scler."},{"key":"8583_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflam 8:184","journal-title":"J Neuroinflam"},{"key":"8583_CR24","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M et al (2016) Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflam 3:e257","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"8583_CR25","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","volume":"2","author":"S-M Kim","year":"2015","unstructured":"Kim S-M, Woodhall MR, Kim J-S et al (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflam 2:e163","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"8583_CR26","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A et al (2014) Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflam 1:e40","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"8583_CR27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00415-015-7983-1","volume":"263","author":"L Piccolo","year":"2016","unstructured":"Piccolo L, Woodhall M, Tackley G et al (2016) Isolated new onset \u201catypical\u201d optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. J Neurol 263:370\u2013379","journal-title":"J Neurol"},{"key":"8583_CR28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","volume":"59","author":"S Tenembaum","year":"2002","unstructured":"Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224\u20131231","journal-title":"Neurology"},{"key":"8583_CR29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/1352458510390068","volume":"17","author":"IA Ketelslegers","year":"2011","unstructured":"Ketelslegers IA, Visser IER, Neuteboom RF et al (2011) Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler 17:441\u2013448","journal-title":"Mult Scler"},{"key":"8583_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0387-7604(12)80271-3","volume":"14","author":"M Hasegawa","year":"1992","unstructured":"Hasegawa M, Houdou S, Mito T et al (1992) Development of myelination in the human fetal and infant cerebrum: a myelin basic protein immunohistochemical study. Brain Dev 14:1\u20136","journal-title":"Brain Dev"},{"key":"8583_CR31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 75:411\u2013428","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8583-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T09:58:54Z","timestamp":1504691934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["8583"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8583-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}